type here...

CATEGORIES

Patient Zone

LATEST

1...323334...59Page 33 of 59

TRENDING

EDITORS CHOICE

COVID-19 Misinformation, Anti-Science, and Conspiracies Theories

Stephen Schimpff, MD MACP -
Covid Conspiracy Theories abound and evidence suggests less educated people are more likely to believe in them. An examination of

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Medika Welcomes Fiona O’Leary to Our Editorial Team

Robert Turner, Founding Editor -
Medika is thrilled to announce that Fiona O'Leary has joined our team. Fiona is best known for years of medical activism in the fields of autism and quackery.

Dallas Researchers Recruiting for Pediatric Migraine Clinical Trial

Dr Jeff Livingston -
Cedar Health Research, located in Dallas and Irving, is currently enrolling candidates in two clinical trials to evaluate the safety and tolerability of Rimegepant

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories